Amgen(AMGN) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist

306.340
-0.520-0.17%

Trading Mar 26 14:26 ET

164.57BMarket Cap40.52P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Fresenius Gets FDA Approval for Biosimilars of Amgen's Bone-condition Drugs
Seeking Alpha5minutes ago
Express News | Live On CNBC, Karen Firestone Announces Bought More HealthEquity; Bought Amgen
Benzinga12:31 ET
The Five-year Decline in Earnings Might Be Taking Its Toll on Amgen (NASDAQ:AMGN) Shareholders as Stock Falls 3.7% Over the Past Week
Simply Wall StMar 26 09:54 ET
Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH
Seeking AlphaMar 26 06:56 ET
Amgen Options Trading: A Deep Dive Into Market Sentiment
BenzingaMar 25 15:15 ET
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
BNN BloombergMar 25 13:51 ET

Comments

jasonbehr87

Mar 19 21:49

$Amgen (AMGN.US)$ oh fuckkk

Teddy123

Mar 8 23:01

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

$Amgen (AMGN.US)$
Can This New Atopic Dermatitis Drug Challenge Current Market Leaders? Phase 3 Data Reveals Key Insights

10xStockPicks

Feb 21 21:57

Esperion Therapeutics On The Verge Of Being Acquired, Upside Could Be Over 500% In The Near Future

$Esperion Therapeutics (ESPR.US)$Esperion Therapeutics (ESPR): A High-Growth Opportunity with Potential 10x Returns
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...

Tao Lao Man Official

Feb 13 05:16

$Amgen (AMGN.US)$
AMGN, MRNA, PFE, JNJ ARE SAME BUS OR NOT = AMGN, MRNA, PFE, JNJ SEM BUT ZAY KO 🤔

Moomoo News Global

Feb 5 21:04

Columns Tariff Investment Opportunities: Four Sectors as Potential Safe Havens

Over the weekend, President Donald Trump announced tariffs on the U.S.'s top three trading partners—Canada, Mexico, and China—and threatened similar measures against the EU. On Monday, U.S. stocks experienced a selloff, with the major indices dropping. Losses narrowed, however, after news broke of a delay in imposing tariffs on Mexico.
Market worries over the tariffs focus on two key issues. U.S. companies that depend heavily ...